Section Arrow
Quote
BIO.NYSE
- Bio-Rad Laboratories IncClass A
Quotes are at least 15-min delayed:2026/03/12 06:53 EDT
Pre Market
Last
 269.89
0 (0.00%)
Bid
109.85
Ask
355.38
High 269.89 
Low 269.89 
Volume 1 
Regular Hours (Closed)
Last
 269.89
+2.04 (+0.76%)
Day High 
270.77 
Prev. Close
267.85 
1-M High
298.96 
Volume 
206.66K 
Bid
109.85
Ask
355.38
Day Low
265.57 
Open
266.42 
1-M Low
251 
Market Cap 
7.23B 
Currency 美元 
P/E 9.62 
%Yield -- 
10-SMA 275.59 
20-SMA 275.72 
50-SMA 295.17 
52-W High 343.12 
52-W Low 211.43 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
27.85/11.52
Enterprise Value
8.58B
Balance Sheet
Book Value Per Share
276.16
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
2.58B
Operating Revenue Per Share
100.79
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
Pre Market 69.55 -0.08 -0.11%
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
Pre Market 109.99 -0.26 -0.24%
MDTMedtronic plc88.97-0.92-1.02%25.14PE
Pre Market 88.95 -0.02 -0.02%
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
Pre Market 1.34 -0.01 -0.74%
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.